{"id":"https://openalex.org/W4309903010","doi":"https://doi.org/10.1002/1878-0261.13342","title":"PI3K\u03b2 inhibition enhances ALK \u2010inhibitor sensitivity in ALK \u2010rearranged lung cancer","display_name":"PI3K\u03b2 inhibition enhances ALK \u2010inhibitor sensitivity in ALK \u2010rearranged lung cancer","publication_year":2022,"publication_date":"2022-11-24","ids":{"openalex":"https://openalex.org/W4309903010","doi":"https://doi.org/10.1002/1878-0261.13342","pmid":"https://pubmed.ncbi.nlm.nih.gov/36423211","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/10158778"},"language":"en","primary_location":{"id":"doi:10.1002/1878-0261.13342","doi":"https://doi.org/10.1002/1878-0261.13342","is_oa":true,"landing_page_url":"https://doi.org/10.1002/1878-0261.13342","pdf_url":null,"source":{"id":"https://openalex.org/S80282989","display_name":"Molecular Oncology","issn_l":"1574-7891","issn":["1574-7891","1878-0261"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","oarl","poland-140","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Oncology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1002/1878-0261.13342","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5077062276","display_name":"Sarang S. Talwelkar","orcid":"https://orcid.org/0000-0001-7047-4058","observed_orcids":["https://orcid.org/0000-0001-7047-4058"]},"institutions":[{"id":"https://openalex.org/I133731052","display_name":"University of Helsinki","ror":"https://ror.org/040af2s02","country_code":"FI","type":"education","lineage":["https://openalex.org/I133731052"]},{"id":"https://openalex.org/I155660961","display_name":"University of Turku","ror":"https://ror.org/05vghhr25","country_code":"FI","type":"education","lineage":["https://openalex.org/I155660961"]},{"id":"https://openalex.org/I4210133586","display_name":"Institute for Molecular Medicine Finland","ror":"https://ror.org/030sbze61","country_code":"FI","type":"facility","lineage":["https://openalex.org/I133731052","https://openalex.org/I4210133586"]},{"id":"https://openalex.org/I4391768107","display_name":"HiLIFE \u2013 El\u00e4m\u00e4ntieteiden Instituutti","ror":"https://ror.org/018bh0m68","country_code":"FI","type":"facility","lineage":["https://openalex.org/I133731052","https://openalex.org/I4391768107"]}],"countries":["FI"],"is_corresponding":false,"raw_author_name":"Sarang S. Talwelkar","raw_affiliation_strings":["Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Finland","Institute of Biomedicine and MediCity Research Laboratories, University of Turku, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Finland","institution_ids":["https://openalex.org/I133731052","https://openalex.org/I4210133586","https://openalex.org/I4391768107"]},{"raw_affiliation_string":"Institute of Biomedicine and MediCity Research Laboratories, University of Turku, Finland","institution_ids":["https://openalex.org/I155660961"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003452123","display_name":"Mikko Ilari M\u00e4yr\u00e4np\u00e4\u00e4","orcid":"https://orcid.org/0000-0002-0877-9640","observed_orcids":["https://orcid.org/0000-0002-0877-9640"]},"institutions":[{"id":"https://openalex.org/I133731052","display_name":"University of Helsinki","ror":"https://ror.org/040af2s02","country_code":"FI","type":"education","lineage":["https://openalex.org/I133731052"]},{"id":"https://openalex.org/I2800394112","display_name":"Helsinki University Hospital","ror":"https://ror.org/02e8hzf44","country_code":"FI","type":"healthcare","lineage":["https://openalex.org/I2800394112","https://openalex.org/I4210166427"]}],"countries":["FI"],"is_corresponding":false,"raw_author_name":"Mikko I. M\u00e4yr\u00e4np\u00e4\u00e4","raw_affiliation_strings":["Department of Pathology, Helsinki University Hospital and University of Helsinki, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pathology, Helsinki University Hospital and University of Helsinki, Finland","institution_ids":["https://openalex.org/I133731052","https://openalex.org/I2800394112"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110357998","display_name":"Julia B. Sch\u00fcler","orcid":"https://orcid.org/0000-0003-1984-7343","observed_orcids":["https://orcid.org/0000-0003-1984-7343"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Julia Sch\u00fcler","raw_affiliation_strings":["Charles River Research Services, Germany GmbH, Freiburg im Breisgau, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Charles River Research Services, Germany GmbH, Freiburg im Breisgau, Germany","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021371196","display_name":"Nora M Linnavirta","orcid":"https://orcid.org/0000-0001-9545-415X","observed_orcids":["https://orcid.org/0000-0001-9545-415X"]},"institutions":[{"id":"https://openalex.org/I133731052","display_name":"University of Helsinki","ror":"https://ror.org/040af2s02","country_code":"FI","type":"education","lineage":["https://openalex.org/I133731052"]},{"id":"https://openalex.org/I4210133586","display_name":"Institute for Molecular Medicine Finland","ror":"https://ror.org/030sbze61","country_code":"FI","type":"facility","lineage":["https://openalex.org/I133731052","https://openalex.org/I4210133586"]},{"id":"https://openalex.org/I4391768107","display_name":"HiLIFE \u2013 El\u00e4m\u00e4ntieteiden Instituutti","ror":"https://ror.org/018bh0m68","country_code":"FI","type":"facility","lineage":["https://openalex.org/I133731052","https://openalex.org/I4391768107"]}],"countries":["FI"],"is_corresponding":false,"raw_author_name":"Nora Linnavirta","raw_affiliation_strings":["Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Finland","institution_ids":["https://openalex.org/I133731052","https://openalex.org/I4210133586","https://openalex.org/I4391768107"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069463210","display_name":"Annabrita Hemmes","orcid":"https://orcid.org/0009-0005-5051-9331","observed_orcids":["https://orcid.org/0009-0005-5051-9331"]},"institutions":[{"id":"https://openalex.org/I133731052","display_name":"University of Helsinki","ror":"https://ror.org/040af2s02","country_code":"FI","type":"education","lineage":["https://openalex.org/I133731052"]},{"id":"https://openalex.org/I4210133586","display_name":"Institute for Molecular Medicine Finland","ror":"https://ror.org/030sbze61","country_code":"FI","type":"facility","lineage":["https://openalex.org/I133731052","https://openalex.org/I4210133586"]},{"id":"https://openalex.org/I4391768107","display_name":"HiLIFE \u2013 El\u00e4m\u00e4ntieteiden Instituutti","ror":"https://ror.org/018bh0m68","country_code":"FI","type":"facility","lineage":["https://openalex.org/I133731052","https://openalex.org/I4391768107"]}],"countries":["FI"],"is_corresponding":false,"raw_author_name":"Annabrita Hemmes","raw_affiliation_strings":["Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Finland","institution_ids":["https://openalex.org/I133731052","https://openalex.org/I4210133586","https://openalex.org/I4391768107"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005235098","display_name":"Simone Adinolfi","orcid":"https://orcid.org/0000-0003-4906-0859","observed_orcids":["https://orcid.org/0000-0003-4906-0859"]},"institutions":[{"id":"https://openalex.org/I175532246","display_name":"University of Eastern Finland","ror":"https://ror.org/00cyydd11","country_code":"FI","type":"education","lineage":["https://openalex.org/I175532246"]}],"countries":["FI"],"is_corresponding":false,"raw_author_name":"Simone Adinolfi","raw_affiliation_strings":["A. I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"A. I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland","institution_ids":["https://openalex.org/I175532246"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000875080","display_name":"Matti Kankainen","orcid":"https://orcid.org/0000-0002-4714-9481","observed_orcids":["https://orcid.org/0000-0002-4714-9481"]},"institutions":[{"id":"https://openalex.org/I133731052","display_name":"University of Helsinki","ror":"https://ror.org/040af2s02","country_code":"FI","type":"education","lineage":["https://openalex.org/I133731052"]},{"id":"https://openalex.org/I4210133586","display_name":"Institute for Molecular Medicine Finland","ror":"https://ror.org/030sbze61","country_code":"FI","type":"facility","lineage":["https://openalex.org/I133731052","https://openalex.org/I4210133586"]},{"id":"https://openalex.org/I4391768107","display_name":"HiLIFE \u2013 El\u00e4m\u00e4ntieteiden Instituutti","ror":"https://ror.org/018bh0m68","country_code":"FI","type":"facility","lineage":["https://openalex.org/I133731052","https://openalex.org/I4391768107"]}],"countries":["FI"],"is_corresponding":false,"raw_author_name":"Matti Kankainen","raw_affiliation_strings":["Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Finland","institution_ids":["https://openalex.org/I133731052","https://openalex.org/I4210133586","https://openalex.org/I4391768107"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049002384","display_name":"Wolfgang Sommergruber","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210119669","display_name":"Boehringer Ingelheim (Austria)","ror":"https://ror.org/026vtvm28","country_code":"AT","type":"company","lineage":["https://openalex.org/I1330995197","https://openalex.org/I4210119669"]}],"countries":["AT"],"is_corresponding":false,"raw_author_name":"Wolfgang Sommergruber","raw_affiliation_strings":["Cancer Cell Signalling Boehringer Ingelheim RCV GmbH & Co KG Vienna Austria","Department of Biotechnology, University of Applied Sciences, Vienna, Austria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Cell Signalling Boehringer Ingelheim RCV GmbH & Co KG Vienna Austria","institution_ids":["https://openalex.org/I4210119669"]},{"raw_affiliation_string":"Department of Biotechnology, University of Applied Sciences, Vienna, Austria","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001075589","display_name":"Anna\u2013Liisa Levonen","orcid":"https://orcid.org/0000-0002-6575-2137","observed_orcids":["https://orcid.org/0000-0002-6575-2137"]},"institutions":[{"id":"https://openalex.org/I175532246","display_name":"University of Eastern Finland","ror":"https://ror.org/00cyydd11","country_code":"FI","type":"education","lineage":["https://openalex.org/I175532246"]}],"countries":["FI"],"is_corresponding":false,"raw_author_name":"Anna\u2010Liisa Levonen","raw_affiliation_strings":["A. I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"A. I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland","institution_ids":["https://openalex.org/I175532246"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042344249","display_name":"Jari Veli R\u00e4s\u00e4nen","orcid":"https://orcid.org/0000-0002-7826-532X","observed_orcids":["https://orcid.org/0000-0002-7826-532X"]},"institutions":[{"id":"https://openalex.org/I2800394112","display_name":"Helsinki University Hospital","ror":"https://ror.org/02e8hzf44","country_code":"FI","type":"healthcare","lineage":["https://openalex.org/I2800394112","https://openalex.org/I4210166427"]}],"countries":["FI"],"is_corresponding":false,"raw_author_name":"Jari R\u00e4s\u00e4nen","raw_affiliation_strings":["Department of Thoracic Surgery, Heart and Lung Center, Helsinki University Hospital, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Thoracic Surgery, Heart and Lung Center, Helsinki University Hospital, Finland","institution_ids":["https://openalex.org/I2800394112"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008969167","display_name":"Aija Knuuttila","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800394112","display_name":"Helsinki University Hospital","ror":"https://ror.org/02e8hzf44","country_code":"FI","type":"healthcare","lineage":["https://openalex.org/I2800394112","https://openalex.org/I4210166427"]}],"countries":["FI"],"is_corresponding":false,"raw_author_name":"Aija Knuuttila","raw_affiliation_strings":["Department of Pulmonary Medicine, Heart and Lung Center and Cancer Center, Helsinki University Hospital, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pulmonary Medicine, Heart and Lung Center and Cancer Center, Helsinki University Hospital, Finland","institution_ids":["https://openalex.org/I2800394112"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018131963","display_name":"Emmy W. Verschuren","orcid":"https://orcid.org/0000-0001-5771-9129","observed_orcids":["https://orcid.org/0000-0001-5771-9129"]},"institutions":[{"id":"https://openalex.org/I133731052","display_name":"University of Helsinki","ror":"https://ror.org/040af2s02","country_code":"FI","type":"education","lineage":["https://openalex.org/I133731052"]},{"id":"https://openalex.org/I2800394112","display_name":"Helsinki University Hospital","ror":"https://ror.org/02e8hzf44","country_code":"FI","type":"healthcare","lineage":["https://openalex.org/I2800394112","https://openalex.org/I4210166427"]},{"id":"https://openalex.org/I4210133586","display_name":"Institute for Molecular Medicine Finland","ror":"https://ror.org/030sbze61","country_code":"FI","type":"facility","lineage":["https://openalex.org/I133731052","https://openalex.org/I4210133586"]},{"id":"https://openalex.org/I4391768107","display_name":"HiLIFE \u2013 El\u00e4m\u00e4ntieteiden Instituutti","ror":"https://ror.org/018bh0m68","country_code":"FI","type":"facility","lineage":["https://openalex.org/I133731052","https://openalex.org/I4391768107"]}],"countries":["FI"],"is_corresponding":true,"raw_author_name":"Emmy W. Verschuren","raw_affiliation_strings":["Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Finland","Translational Cancer Medicine Research Program, Faculty of Medicine, University of Helsinki and Helsinki University Hospital, Finland","iCAN Digital Precision Cancer Medicine Flagship, Finland"],"raw_orcid":"https://orcid.org/0000-0001-5771-9129","affiliations":[{"raw_affiliation_string":"Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Finland","institution_ids":["https://openalex.org/I133731052","https://openalex.org/I4210133586","https://openalex.org/I4391768107"]},{"raw_affiliation_string":"Translational Cancer Medicine Research Program, Faculty of Medicine, University of Helsinki and Helsinki University Hospital, Finland","institution_ids":["https://openalex.org/I133731052","https://openalex.org/I2800394112"]},{"raw_affiliation_string":"iCAN Digital Precision Cancer Medicine Flagship, Finland","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5067760174","display_name":"Krister Wennerberg","orcid":"https://orcid.org/0000-0002-1352-4220","observed_orcids":["https://orcid.org/0000-0002-1352-4220"]},"institutions":[{"id":"https://openalex.org/I124055696","display_name":"University of Copenhagen","ror":"https://ror.org/035b05819","country_code":"DK","type":"education","lineage":["https://openalex.org/I124055696"]},{"id":"https://openalex.org/I133731052","display_name":"University of Helsinki","ror":"https://ror.org/040af2s02","country_code":"FI","type":"education","lineage":["https://openalex.org/I133731052"]},{"id":"https://openalex.org/I2801134892","display_name":"Novo Nordisk Foundation","ror":"https://ror.org/04txyc737","country_code":"DK","type":"facility","lineage":["https://openalex.org/I2801134892"]},{"id":"https://openalex.org/I4210133586","display_name":"Institute for Molecular Medicine Finland","ror":"https://ror.org/030sbze61","country_code":"FI","type":"facility","lineage":["https://openalex.org/I133731052","https://openalex.org/I4210133586"]},{"id":"https://openalex.org/I4391768107","display_name":"HiLIFE \u2013 El\u00e4m\u00e4ntieteiden Instituutti","ror":"https://ror.org/018bh0m68","country_code":"FI","type":"facility","lineage":["https://openalex.org/I133731052","https://openalex.org/I4391768107"]}],"countries":["DK","FI"],"is_corresponding":true,"raw_author_name":"Krister Wennerberg","raw_affiliation_strings":["Biotech Research & Innovation Centre (BRIC) and Novo Nordisk Foundation Center for Stem Cell Biology (DanStem) University of Copenhagen Denmark","Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Finland"],"raw_orcid":"https://orcid.org/0000-0002-1352-4220","affiliations":[{"raw_affiliation_string":"Biotech Research & Innovation Centre (BRIC) and Novo Nordisk Foundation Center for Stem Cell Biology (DanStem) University of Copenhagen Denmark","institution_ids":["https://openalex.org/I124055696","https://openalex.org/I2801134892"]},{"raw_affiliation_string":"Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Finland","institution_ids":["https://openalex.org/I133731052","https://openalex.org/I4210133586","https://openalex.org/I4391768107"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":9,"corresponding_author_ids":["https://openalex.org/A5018131963","https://openalex.org/A5067760174"],"corresponding_institution_ids":["https://openalex.org/I124055696","https://openalex.org/I133731052","https://openalex.org/I2800394112","https://openalex.org/I2801134892","https://openalex.org/I4210133586","https://openalex.org/I4391768107"],"apc_list":{"value":3800,"currency":"USD","value_usd":3800},"apc_paid":{"value":3800,"currency":"USD","value_usd":3800},"fwci":1.2895,"has_fulltext":true,"cited_by_count":13,"citation_normalized_percentile":{"value":0.80861273,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":99},"biblio":{"volume":"17","issue":"5","first_page":"747","last_page":"764"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12334","display_name":"Lung Cancer Research Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/alk-rearrangement","display_name":"ALK rearrangement","score":0.7260000109672546},{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.9259999990463257},{"id":"https://openalex.org/keywords/alk-inhibitors","display_name":"ALK inhibitors","score":0.8360000252723694},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.8830000162124634},{"id":"https://openalex.org/keywords/egfr-activation","display_name":"EGFR activation","score":0.8659999966621399},{"id":"https://openalex.org/keywords/mapk-signaling","display_name":"MAPK signaling","score":0.7919999957084656},{"id":"https://openalex.org/keywords/pi3k-akt-signaling","display_name":"PI3K/Akt signaling","score":0.9089999794960022},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.9319999814033508},{"id":"https://openalex.org/keywords/tp53-mutation","display_name":"TP53 mutation","score":0.8930000066757202},{"id":"https://openalex.org/keywords/epithelial-mesenchymal-transition","display_name":"epithelial-mesenchymal transition","score":0.9399999976158142},{"id":"https://openalex.org/keywords/targeted-therapy","display_name":"targeted therapy","score":0.48500001430511475}],"concepts":[{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5611271858215332},{"id":"https://openalex.org/C2778347629","wikidata":"https://www.wikidata.org/wiki/Q4652380","display_name":"ALK inhibitor","level":5,"score":0.5503043532371521},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.5354680418968201},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.3943351209163666},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2367534637451172},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.21419209241867065},{"id":"https://openalex.org/C117643217","wikidata":"https://www.wikidata.org/wiki/Q17824987","display_name":"Anaplastic lymphoma kinase","level":4,"score":0.193821519613266},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.12814277410507202},{"id":"https://openalex.org/C2776232967","wikidata":"https://www.wikidata.org/wiki/Q6743514","display_name":"Malignant pleural effusion","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000077548","descriptor_name":"Anaplastic Lymphoma Kinase","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D002289","descriptor_name":"Carcinoma, Non-Small-Cell Lung","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D002289","descriptor_name":"Carcinoma, Non-Small-Cell Lung","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D002289","descriptor_name":"Carcinoma, Non-Small-Cell Lung","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D019869","descriptor_name":"Phosphatidylinositol 3-Kinases","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020794","descriptor_name":"Receptor Protein-Tyrosine Kinases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D066246","descriptor_name":"ErbB Receptors","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false}],"locations_count":7,"locations":[{"id":"doi:10.1002/1878-0261.13342","doi":"https://doi.org/10.1002/1878-0261.13342","is_oa":true,"landing_page_url":"https://doi.org/10.1002/1878-0261.13342","pdf_url":null,"source":{"id":"https://openalex.org/S80282989","display_name":"Molecular Oncology","issn_l":"1574-7891","issn":["1574-7891","1878-0261"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","oarl","poland-140","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Oncology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:10158778","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10158778","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Mol Oncol","raw_type":"Text"},{"id":"pmid:36423211","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/36423211","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular oncology","raw_type":"Journal Article"},{"id":"pmh:oai:pure.atira.dk:openaire/b2670bc5-99d6-4a05-a26f-eb8561d2e5c7","doi":null,"is_oa":true,"landing_page_url":"https://researchprofiles.ku.dk/da/publications/b2670bc5-99d6-4a05-a26f-eb8561d2e5c7","pdf_url":null,"source":{"id":"https://openalex.org/S4306401983","display_name":"Research at the University of Copenhagen (University of Copenhagen)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I124055696","host_organization_name":"University of Copenhagen","host_organization_lineage":["https://openalex.org/I124055696"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Talwelkar, S S, Mayranpaa, M I, Schuler, J, Linnavirta, N, Hemmes, A, Adinolfi, S, Kankainen, M, Sommergruber, W, Levonen, A-L, Rasanen, J, Knuuttila, A, Verschuren, E W & Wennerberg, K 2023, 'PI3K\u03b2 inhibition enhances ALK-inhibitor sensitivity in ALK -rearranged lung cancer', Molecular Oncology, vol. 17, no. 5, pp. 747-764. https://doi.org/10.1002/1878-0261.13342","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:utupub.fi:11111/49977","doi":null,"is_oa":true,"landing_page_url":"https://www.utupub.fi/handle/11111/49977","pdf_url":"https://www.utupub.fi/bitstreams/6fc96ca0-d93d-4be9-9e5b-f55f11b951fb/download","source":{"id":"https://openalex.org/S4306402470","display_name":"UTUPub (University of Turku)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I155660961","host_organization_name":"University of Turku","host_organization_lineage":["https://openalex.org/I155660961"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"https://www.utupub.fi/handle/10024/192963","raw_type":null},{"id":"pmh:oai:doaj.org/article:1563d14766b740a0a1ffecc8176e6bc3","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/1563d14766b740a0a1ffecc8176e6bc3","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Molecular Oncology, Vol 17, Iss 5, Pp 747-764 (2023)","raw_type":"article"},{"id":"pmh:oai:www.utupub.fi:10024/192963","doi":null,"is_oa":false,"landing_page_url":"https://www.utupub.fi/handle/10024/192963","pdf_url":null,"source":{"id":"https://openalex.org/S4306402470","display_name":"UTUPub (University of Turku)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I155660961","host_organization_name":"University of Turku","host_organization_lineage":["https://openalex.org/I155660961"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":{"id":"doi:10.1002/1878-0261.13342","doi":"https://doi.org/10.1002/1878-0261.13342","is_oa":true,"landing_page_url":"https://doi.org/10.1002/1878-0261.13342","pdf_url":null,"source":{"id":"https://openalex.org/S80282989","display_name":"Molecular Oncology","issn_l":"1574-7891","issn":["1574-7891","1878-0261"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","oarl","poland-140","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.98580002784729,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G155838707","display_name":null,"funder_award_id":"NNF21SA0073733","funder_id":"https://openalex.org/F4320325957","funder_display_name":"Novo Nordisk Fonden"},{"id":"https://openalex.org/G2163411231","display_name":null,"funder_award_id":"740264","funder_id":"https://openalex.org/F4320332999","funder_display_name":"Horizon 2020 Framework Programme"},{"id":"https://openalex.org/G2275658407","display_name":"Genomics and Mechanisms in Translational Medicine Doctoral Programme","funder_award_id":"740264","funder_id":"https://openalex.org/F4320320300","funder_display_name":"European Commission"},{"id":"https://openalex.org/G2918446145","display_name":null,"funder_award_id":"NNF17CC0027852","funder_id":"https://openalex.org/F4320332999","funder_display_name":"Horizon 2020 Framework Programme"},{"id":"https://openalex.org/G3589578894","display_name":null,"funder_award_id":"NNF17CC0027852","funder_id":"https://openalex.org/F4320325957","funder_display_name":"Novo Nordisk Fonden"},{"id":"https://openalex.org/G399059165","display_name":null,"funder_award_id":"307111","funder_id":"https://openalex.org/F4320321108","funder_display_name":"Academy of Finland"},{"id":"https://openalex.org/G54864864","display_name":"Development of new antimicrobial nanostructured durable coatings for fuel tanks","funder_award_id":"307111","funder_id":"https://openalex.org/F4320320300","funder_display_name":"European Commission"},{"id":"https://openalex.org/G7044228676","display_name":null,"funder_award_id":"NNF17CC0027852","funder_id":"https://openalex.org/F4320322436","funder_display_name":"Novo Nordisk"},{"id":"https://openalex.org/G8447710727","display_name":"Transcription factor NRF2 in lung cancer","funder_award_id":"332697","funder_id":"https://openalex.org/F4320321108","funder_display_name":"Academy of Finland"}],"funders":[{"id":"https://openalex.org/F4320310086","display_name":"Helsingin Yliopisto","ror":"https://ror.org/040af2s02"},{"id":"https://openalex.org/F4320310467","display_name":"Helsingin ja Uudenmaan Sairaanhoitopiiri","ror":"https://ror.org/020cpqb94"},{"id":"https://openalex.org/F4320310751","display_name":"Suomen L\u00e4\u00e4ketieteen S\u00e4\u00e4ti\u00f6","ror":"https://ror.org/0593mby10"},{"id":"https://openalex.org/F4320320300","display_name":"European Commission","ror":"https://ror.org/00k4n6c32"},{"id":"https://openalex.org/F4320321108","display_name":"Academy of Finland","ror":"https://ror.org/05k73zm37"},{"id":"https://openalex.org/F4320322135","display_name":"Biomedicum Helsinki-s\u00e4\u00e4ti\u00f6","ror":"https://ror.org/02e8hzf44"},{"id":"https://openalex.org/F4320322436","display_name":"Novo Nordisk","ror":"https://ror.org/0435rc536"},{"id":"https://openalex.org/F4320323760","display_name":"Sigrid Jus\u00e9liuksen S\u00e4\u00e4ti\u00f6","ror":"https://ror.org/00ckakm23"},{"id":"https://openalex.org/F4320325592","display_name":"K. Albin Johanssons Stiftelse","ror":"https://ror.org/03arxxe13"},{"id":"https://openalex.org/F4320325957","display_name":"Novo Nordisk Fonden","ror":"https://ror.org/04txyc737"},{"id":"https://openalex.org/F4320326591","display_name":"Sy\u00f6p\u00e4s\u00e4\u00e4ti\u00f6","ror":"https://ror.org/0113k5861"},{"id":"https://openalex.org/F4320332999","display_name":"Horizon 2020 Framework Programme","ror":"https://ror.org/00k4n6c32"},{"id":"https://openalex.org/F4320333873","display_name":"Helsinki Institute of Life Science, Helsingin Yliopisto","ror":"https://ror.org/018bh0m68"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":41,"referenced_works":["https://openalex.org/W1969391810","https://openalex.org/W1992477322","https://openalex.org/W2002783575","https://openalex.org/W2046844445","https://openalex.org/W2051613731","https://openalex.org/W2055402151","https://openalex.org/W2082020673","https://openalex.org/W2091493266","https://openalex.org/W2096156234","https://openalex.org/W2099530756","https://openalex.org/W2100288916","https://openalex.org/W2113327188","https://openalex.org/W2136245016","https://openalex.org/W2140333474","https://openalex.org/W2145722025","https://openalex.org/W2156918228","https://openalex.org/W2168691181","https://openalex.org/W2285453897","https://openalex.org/W2334089645","https://openalex.org/W2471664064","https://openalex.org/W2581592505","https://openalex.org/W2581675136","https://openalex.org/W2584719393","https://openalex.org/W2624310346","https://openalex.org/W2725020420","https://openalex.org/W2768987816","https://openalex.org/W2775798067","https://openalex.org/W2789281724","https://openalex.org/W2789632821","https://openalex.org/W2790705494","https://openalex.org/W2792983998","https://openalex.org/W2799754007","https://openalex.org/W2889170871","https://openalex.org/W2908256106","https://openalex.org/W2964191865","https://openalex.org/W2997667638","https://openalex.org/W3008396392","https://openalex.org/W3010256878","https://openalex.org/W3016720073","https://openalex.org/W3124786886","https://openalex.org/W4220672244"],"related_works":["https://openalex.org/W3138582097","https://openalex.org/W1993650372","https://openalex.org/W2898552019","https://openalex.org/W4255243539","https://openalex.org/W2803748970","https://openalex.org/W2758151171","https://openalex.org/W2740978652","https://openalex.org/W4234910992","https://openalex.org/W7148846727","https://openalex.org/W4408660579"],"abstract_inverted_index":{"Treatment":[0],"with":[1,16],"anaplastic":[2],"lymphoma":[3],"kinase":[4],"(ALK)":[5],"inhibitors":[6],"significantly":[7],"improves":[8],"outcome":[9],"for":[10,65,156],"non-small-cell":[11],"lung":[12],"cancer":[13,125],"(NSCLC)":[14],"patients":[15],"ALK-rearranged":[17,46,106,157],"tumors.":[18],"However,":[19],"clinical":[20,47],"resistance":[21,32,75],"typically":[22],"develops":[23],"over":[24],"time":[25],"and,":[26],"in":[27,70,133,140],"the":[28,72,109,117,124,134],"majority":[29],"of":[30,44,58,80,84,103,112,136],"cases,":[31],"mechanisms":[33],"are":[34],"ALK-independent.":[35],"We":[36],"generated":[37],"tumor":[38,48],"cell":[39],"cultures":[40],"from":[41],"multiple":[42],"regions":[43],"an":[45],"specimen":[49],"and":[50,67,86,89,114,121,139,148],"deployed":[51],"functional":[52],"drug":[53],"screens":[54],"to":[55,76,94],"identify":[56],"modulators":[57],"ALK-inhibitor":[59,119],"response.":[60],"This":[61],"identified":[62],"a":[63,154],"role":[64],"PI3K\u03b2":[66,115],"EGFR":[68],"inhibition":[69,100,111],"sensitizing":[71],"response":[73],"regulating":[74],"ALK":[77,81,95,113],"inhibition.":[78],"Inhibition":[79],"elicited":[82],"activation":[83],"EGFR,":[85],"subsequent":[87],"MAPK":[88],"PI3K-AKT":[90],"pathway":[91],"reactivation.":[92],"Sensitivity":[93],"targeting":[96],"was":[97,130],"enhanced":[98],"by":[99],"or":[101],"knockdown":[102],"PI3K\u03b2.":[104],"In":[105,144],"primary":[107],"cultures,":[108],"combined":[110],"prevented":[116],"EGFR-mediated":[118],"resistance,":[120],"selectively":[122],"targeted":[123],"cells.":[126,143],"The":[127],"combinatorial":[128,146],"effect":[129],"seen":[131],"also":[132],"background":[135],"TP53":[137],"mutations":[138],"epithelial-to-mesenchymal":[141],"transformed":[142],"conclusion,":[145],"ALK-":[147],"PI3K\u03b2-inhibitor":[149],"treatment":[150,155],"carries":[151],"promise":[152],"as":[153],"NSCLC.":[158]},"counts_by_year":[{"year":2026,"cited_by_count":5},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2022-11-30T00:00:00"}